Sometimes you have to start with your article, and go fishing for another
From this article:
The U.S. agencies, however, said GlaxoSmithKline (GSK.L) and Vir Biotechnology's (VIR.O) rival drug sotrovimab appeared to work against Omicron.
Sotrovimab shipments, which were paused last month pending efficacy data against the variant, have resumed and delivery of 55,000 doses of the drug has begun, the agencies said. (https://bit.ly/3EpPqcX)
VaTechie
make sure you go to https://bit.ly/3EpPqcX
You will see Regeneron doses down, but are replaced by the other two. The total does seem to be the same.
So the question is: do we need more total doses? I will wait for Let's Go @TomKazanski to make that decision for us since he is so concerned with government spending and implementation of anything.
[Post edited by VaTechie at 12/30/2021 9:57PM]
|
(
In response to this post by Hoodafan)
Link: Stop one drug, start another drug seems to be the real story
Posted: 12/30/2021 at 9:52PM